Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


karthik.ramasamy@ndorms.ox.ac.uk

Karthik Ramasamy

Professor of Haematology/ Director of Oxford Translational Myeloma Centre

IMPROVING OUTCOMES FOR PATIENTS WITH PLASMA CELL DYSCRASIAS


Karthik Ramasamy is a Consultant Haematologist at Oxford University Hospitals NHS Trust and Professor of Haematology, NDORMS, University of Oxford, UK. Prof Ramasamy is the Director of the Oxford Translational Myeloma Centre.

Prof Ramasamy leads Cancer and Haematology Research at Oxford University Hospitals. Prof Ramasamy serves on the International Myeloma Society Educational committee and is an active member of UK Myeloma Research Alliance.

Karthik is an ambassador and previous Director of Myeloma UK, a patient charity exclusively dealing with myeloma advocacy and research. Karthik completed his haematology training at King College Hospitals, London. Following this, he completed three years as a clinical research fellow working on bone marrow microenvironment in myeloma at King’s College London. Prof Ramasamy is a Chief Investigator of myeloma studies and his academic research interests are precursor disease states ( MGUS and Smouldering myeloma), personalised care of myeloma patients and myeloma drug resistance mechanisms. Karthik has published over 150 papers and authored textbooks/ chapters on myeloma.